中枢神经系统疾病及其药物与蛋白质组学研究进展

The progress in the proteomics researches of central nervous system diseases and drugs

阐述中枢神经系统疾病及其药物蛋白质组学研究的最新进展。蛋白质组学是后基因组时代的一门重要学科 ,是从整体水平对蛋白质进行综合分析 ,目前已广泛应用于临床和生物医学各个领域。蛋白质组学研究有助于阐明CNS疾病发生、发展、转归的网络机制 ,寻找疾病特异性蛋白质 ,针对疾病靶点定向合成药物 ,构建分子药理模型 ,高通量地筛选和评价药物的效应及毒副作用。可以预见 ,蛋白质组学将为CNS疾病的诊断。

To elucidate the latest progress of proteomics research of central nervous system diseases and drugs. Proteomics , an important discipline in postgenomic era, is the integrated study of protein properties on a large scale. Currently, the best established application of proteomics are in the clinical and biomedical fields. Proteomics will facilitate the elucidation of network mechanism of the development, progress and prognosis of central nervous system diseases. Proteomics offer a unique opportunity to identify disease specific proteins, accelerate the development of target driven drugs, build up molecular pharmacological models, screen and analysis of the efficacy, toxicity and side effects of potential drugs on a large scale. It is predictable that proteomics will play a tremendous role for the diagnosis, detection and pharmaceutical development of central nervous system diseases.